Dharmaj Crop Guard releases Consolidated Quarterly Results for December 31, 2022.
Dharmaj Crop Guard Quarterly Results (Q3 FY2023) – Quarter-over-Quarter Comparison:
Total income of the company is Rs.101.621 Crores (December 31, 2022) vs. Rs.222.511 Crores (September 30, 2022)
Net profit/loss: Rs.5.498 Crores (December 31, 2022) vs. Rs.16.170 Crores (September 30, 2022)
EPS: Rs.1.63 (December 31, 2022) vs. Rs.6.55 (September 30, 2022)
Financials | Q3 FY2023 | Q2 FY2023 | % Change |
Total Income | ₹101.621 Cr | ₹222.511 Cr | ⬇ -54.32 |
Net Profit | ₹5.498 Cr | ₹16.170 Cr | ⬇ -65.99 |
EPS | ₹1.63 | ₹6.55 | ⬇ -75.11 |
Dharmaj Crop Guard Quarterly Results (Q3 FY2023) – Year-over-Year Comparison:
Total income of the company is Rs.101.621 Crores (December 31, 2022) vs. Rs.107.543 Crores (December 31, 2022)
Net profit/loss: Rs.5.498 Crores (December 31, 2022) vs. Rs.8.285 Crores (December 31, 2022)
EPS: Rs.1.63 (December 31, 2022) vs. Rs.3.36 (December 31, 2022)
Financials | Q3 FY2023 | Q3 FY2022 | % Change |
Total Income | ₹101.621 Cr | ₹107.543 Cr | ⬇ -5.50% |
Net Profit | ₹5.498 Cr | ₹8.285 Cr | ⬇ -33.63% |
EPS | ₹1.63 | ₹3.36 | ⬇ -51.48 |
Dharmaj Crop Guard Quarterly Results (9 Months Ended FY2023) – Year-over-Year Comparison:
Total income of the company is Rs.461.309 Crores (December 31, 2022) vs. Rs.294.036 Crores (December 31, 2021)
Net profit/loss: Rs.31.862 Crores (December 31, 2022) vs. Rs.26.342 Crores (December 31, 2021)
EPS: Rs.9.43 (December 31, 2022) vs. Rs.10.67 (December 31, 2021)
Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
Total Income | ₹461.309 Cr | ₹294.036 Cr | ⬆ 56.88% |
Net Profit | ₹31.862 Cr | ₹26.342 Cr | ⬆ 20.95% |
EPS | ₹9.43 | ₹10.67 | ⬇ -11.62% |
About Dharmaj Crop Guard:
Incorporated in 2015, Dharmaj Crop Guard Limited is an agrochemical company. The company is engaged in the business of manufacturing, distributing, and marketing a wide range of agrochemical formulations such as insecticides, fungicides, herbicides, plant growth regulators, micro fertilizers, and antibiotics to B2C and B2B customers.
For More Latest News Click Here